Alexandre Jourdan, Vice President in Baird’s Global Healthcare Investment Group, was featured in the April edition of Financial Services Review. In the article, Alexandre provides commentary on global M&A activity and spotlights the middle-market, which is ramping up in activity after a slower 2023 in most sectors, including Healthcare. Alexandre also provides perspectives on the Medical Technology (MedTech) sector.

Read the full article on

Alexandre Jourdan